Gilead Down on Sovaldi Price Issue – Analyst Blogby Bob MitchellMarch 24, 2014April 17, 2021Gilead Sciences Inc. ‘s ( GILD ) pricing of its hepatitis C virus (HCV) drug, Sovaldi, came under the scanner …read more